Recruiting Atrial Fibrillation Studies in New Brunswick
About Atrial Fibrillation Clinical Trials in New Brunswick
Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.
There are currently 1 atrial fibrillation clinical trials recruiting participants in New Brunswick, NJ. These studies are seeking a combined 466 participants. Research is being sponsored by Biosense Webster, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atrial Fibrillation Clinical Trials in New Brunswick — FAQ
Are there atrial fibrillation clinical trials in New Brunswick?
Yes, there are 1 atrial fibrillation clinical trials currently recruiting in New Brunswick, NJ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Brunswick?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Brunswick research site will contact you about next steps.
Are clinical trials in New Brunswick free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Brunswick studies also compensate for your time and travel.
What atrial fibrillation treatments are being tested?
The 1 active trials in New Brunswick are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.
Data updated July 18, 2026 from ClinicalTrials.gov